Recent Progress of Nanocarrier-Based Therapy for Solid Malignancies

SIMPLE SUMMARY: Although conventional anti-cancer drugs have been the footstone in the fight against cancer, yet they are far from optimal due to issues related with indiscriminate destruction of normal cells, multidrug resistance, and toxicity, as a result, a more selective therapy is urgently need...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Qi-Yao, Xu, Yan-Ming, Lau, Andy T. Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600685/
https://www.ncbi.nlm.nih.gov/pubmed/32998391
http://dx.doi.org/10.3390/cancers12102783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600685/
https://www.ncbi.nlm.nih.gov/pubmed/32998391
http://dx.doi.org/10.3390/cancers12102783

Ejemplares similares